ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Insider Masaru Matsuda sold $72K of Arcutis Biotherapeutics, Inc.
Sold$72,135
$28.29Price
2,550Shares
−2%Stake
What ARQT did after the filing
- The stock from Mon, Nov 24 open, $29.84
- +0.2%
- S&P 500, same days
- +4.9%
Measured over 30 trading days, to the Jan 8 close.
Traded Wed, Nov 19. Filed Fri, Nov 21, 6:34 PM ET, after the close. Returns use the Nov 24 open and the Jan 8 close. Not investment advice.